Brief: Interpace Diagnostics Announces Notice Of Allowance From U.S. Patent And Trademark Office Covering Barregen
Dec 17 (Reuters) - Interpace Diagnostics Group Inc IDXG.O :
* INTERPACE ANNOUNCES NOTICE OF ALLOWANCE FROM U.S. PATENT
AND
TRADEMARK OFFICE COVERING BARREGEN®
* INTERPACE DIAGNOSTICS GROUP INC - PATENT, WHEN ISSUED, IS
EXPECTED TO HAVE A TERM THAT EXPIRES IN 2032
Source text for Eikon: ID:nGNXbyV1Ws
Further company coverage: IDXG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million